RT Journal Article
SR Electronic
T1 Deoxycholic acid liganded HBs contributes to HBV maturation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.21.21268182
DO 10.1101/2021.12.21.21268182
A1 Yuxue Gao
A1 Qiqi Ning
A1 Pengxiang Yang
A1 Yulin Zhang
A1 Yuanyue Guan
A1 Ning Liu
A1 Haijing Ben
A1 Yang Wang
A1 Mengcheng Liu
A1 Tongwang Yang
A1 Yuying Cai
A1 Zhongjie Hu
A1 Mengxi Jiang
A1 Dexi Chen
YR 2021
UL http://medrxiv.org/content/early/2021/12/30/2021.12.21.21268182.abstract
AB Understanding the underlying mechanism of HBV maturation and subviral particle production is critical to control HBV infection and develop new antiviral strategies. Here, we demonstrate that deoxycholic acid (DCA) plays a central role in HBV production. HBV infection increased DCA levels, whereas elimination of DCA-producing microbiome decreased HBV viral load. DCA can bind to HBs antigen via LXXLL motif at TM1 and TM2 region to regulate HBs-HBc interaction and the production of mature HBV. Plasma DCA levels from patients undergoing antiviral therapy were significantly higher in those with positive HBV viral load. These results suggest that intestinal DCA-producing microbiome can affect the efficiency of antiviral therapy and provide a potential novel strategy for HBV antiviral therapy.One Sentence Summary We demonstrate that DCA-promoted HBs-HBc interaction and contributes to HBV maturation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Natural Science Foundation of China grant 82073676Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Beijing You An hospital gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors